Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical leader with a century-long legacy of scientific innovation and a relentless focus on transforming patients' lives. Headquartered in Princeton, New Jersey, the company discovers, develops, and delivers innovative medicines for some of the world's most serious diseases, including cancer, cardiovascular conditions, immunology, fibrosis, and neuroscience. With a robust pipeline and a portfolio of breakthrough therapies, including immuno-oncology treatments that have redefined cancer care, BMS combines deep scientific expertise with a patient-first mission. Operating across more than 50 countries and employing tens of thousands of people worldwide, the company partners with healthcare providers, researchers, and communities to advance medicine and improve outcomes for patients facing life-threatening illnesses.
Greg Meyers
EVP & Chief Digital and Technology Officer at Bristol Myers Squibb
Transforming Cancer Diagnoses and Treatment with Bristol Myers Squibb CTO Greg Meyers
On the 69th episode of Enterprise AI Innovators, Greg Meyers, Chief Digital and Technology Officer at Bristol Myers Squibb, joins the show to share how the pharmaceutical company is rebuilding drug discovery and clinical work around AI by learning to treat itself as a data company, and how small, time-boxed experiments are changing what a highly regulated research organization believes it can attempt.